VERFAHREN ZUR VERMEIDUNG UND ZUR BEHANDLUNG EINER HYPERPERMEABILITÄT
    4.
    发明公开
    VERFAHREN ZUR VERMEIDUNG UND ZUR BEHANDLUNG EINER HYPERPERMEABILITÄT 有权
    VERFAHREN ZUR VERMEIDUNG UND ZUR BEHANDLUNG EINERHYPERPERMEABILITÄT

    公开(公告)号:EP2403519A1

    公开(公告)日:2012-01-11

    申请号:EP10709949.1

    申请日:2010-03-05

    IPC分类号: A61K38/19

    CPC分类号: C07K7/64 A61K38/12 A61K38/191

    摘要: The invention relates to a peptide consisting of 7-17 adjoining amino acids and comprising the hexamer TX
    1 EX
    2 X
    3 E, where X
    1 , X
    2 and X
    3 can each be a natural or non-natural amino acid, wherein the peptide has no TNF receptor binding activity and is cyclized, for preventing and treating the hyperpermeability of epithelial cells and endothelial cells.

    摘要翻译: 描述了一种肽,其由7-17个相邻氨基酸组成并且包含六聚体TX EX XE,其中X,X和X可以是任何天然或非天然氨基酸,其中所述肽不具有TNF受体结合活性,并且是 环化,用于预防和治疗上皮细胞和内皮细胞的高渗透性。

    ZYKLISCHES, CYSTEIN-FREIES PROTEIN
    5.
    发明公开
    ZYKLISCHES, CYSTEIN-FREIES PROTEIN 有权
    循环,半胱氨酸游离蛋白

    公开(公告)号:EP2217619A1

    公开(公告)日:2010-08-18

    申请号:EP08859641.6

    申请日:2008-12-12

    IPC分类号: C07K14/525 A61K38/19

    CPC分类号: A61K38/191 C07K14/525

    摘要: The invention relates to a protein which is selected from the amino acid sequence of the region valine Val(91) to glycine Gly(121) of the mature, human tumor necrosis factor, or a part thereof, provided that the protein comprises at least the amino acid sequence of the region lysine Lys(98) to glutamic acid Glu(116), the cysteine Cys(101) being replaced by a glycine and an amide bond being formed between the amino group of the side chain of the lysine Lys(98) and the carboxyl group of the side chain of the glutamic acid Glu(116). The protein activates epithelial ion channels and improves the pulmonary function and can be used to produce drugs for the treatment of diseases that are associated with the pulmonary function, such as oedema.

    PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR BEHANDLUNG DER DURCH SAUERSTOFFARMUT UND VERRINGERTEN LUFTDRUCK VERMITTELTEN PULMONALEN FORM DER HÖHENKRANKHEIT
    10.
    发明公开
    PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR BEHANDLUNG DER DURCH SAUERSTOFFARMUT UND VERRINGERTEN LUFTDRUCK VERMITTELTEN PULMONALEN FORM DER HÖHENKRANKHEIT 有权
    是氧气由于贫困,减少治疗压力的药物组合物交换式肺病形成高度

    公开(公告)号:EP2866824A1

    公开(公告)日:2015-05-06

    申请号:EP13730877.1

    申请日:2013-06-19

    IPC分类号: A61K38/19 A61P11/00

    CPC分类号: C07K7/64 A61K38/191

    摘要: What is described is a peptide which consists of 7‑20, especially 7‑17, adjacent amino acids and comprises the hexamer TX
    1 EX
    2 X
    3 E where X
    1 , X
    2 and X
    3 may be any natural or unnatural amino acid, where the peptide does not have any TNF receptor binding activity and is cyclized, for use for the treatment and avoidance of the pulmonary form of altitude sickness.

    摘要翻译: 肽包含7-17个连续氨基酸和六聚体,其中所述肽不包含,肿瘤坏死因子(TNF)受体结合活性和环化,是新的。 肽包含7-17个连续氨基酸和式(TX1EX2X3E),其中所述肽不包含,肿瘤坏死因子(TNF)受体结合活性和环化,是新的六聚体。 X1,X2,X3:天然或非天然的氨基酸。 N.B:T和E的没有定义。 一个独立的claimsoft包含用于组合物包含所述肽,所有这些在施用给人类,和载体组合物配制。 活动:没有给出。 作用机理:没有给出。